Minerva Neurosciences | NERV - Процентные расходы





Процентные расходы Изменить Дата
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Adma Biologics USD 2.1M 474K 2026-03
ALKERMES USD 25.92M 5.03M 2026-06
AstraZeneca USD 340M 144M 2026-06
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
Bristol-Myers Squibb USD 407M 4M 2026-06
Cipla INR 170.3M 39M 2026-06
Compugen USD 1.35M 399K 2026-03
CSL USD 215M 111M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
GlaxoSmithKline GBP 121M 46M 2026-06
Grifols EUR 156.07M 31.46M 2025-09
Halozyme Therapeutics USD 5.59M 80K 2026-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
J&J USD 43M 25M 2026-03
Merck USD 525M 46M 2026-06
Minerva Neurosciences USD 2.31M 60K 2024-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 462M 119M 2026-06
Novavax USD 5.82M 342K 2025-12
Pfizer USD 667M 4M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
Takeda JPY 63.85B 20.2B 2026-06
Vanda Pharmaceuticals -1.37B 1.97B 2025-12